One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Oral immediate-release source; do not transfer to IV or extended-release minocycline. Historical infection regimens are not current preferred-therapy determinations.
The MINOCIN IV label sets a renal-impairment ceiling of 200 mg per 24 hours. UCSF lists a 200-mg loading dose followed by 100 mg every 12 hours without renal adjustment, and selected higher-dose treatment with specialist input. Initial-day exposure or high-dose maintenance can exceed the label ceiling.
What to reconcile: This is a real exposure difference, not just alternate wording. Obtain infectious-disease/antimicrobial-stewardship input and document the exact IV product, indication, renal status, total first-day exposure and monitoring before choosing an approach. Do not silently merge the label cap with an institutional schedule.
Open this note and its source referencesThe label describes incompletely characterized pharmacokinetics at CrCl below 80 mL/min and limits the total dose in renal impairment to 200 mg per 24 hours. Monitor BUN and creatinine. This IV formulation contains magnesium sulfate; monitor serum magnesium in renal impairment. The usual adult non-renal regimen is a 200-mg initial dose followed by 100 mg every 12 hours over 60 minutes, but do not automatically apply that loading exposure above the renal daily cap. See the separately displayed institutional regimen and documented difference.
RDM34-official-minocycline-label-C1 · Source locator: Dosage and administration: adults and renal impairment; warnings for magnesium-containing formulation.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=minocycline&s1=RDM34-official-minocycline-label&h1=9dcdca57da7014b538dd8e260375815d9fbbc52771388cef6863259a63413d15